p62 is a useful predictive marker for tumour regression after chemoradiation therapy in patients with advanced rectal cancer: an immunohistochemical study-Reference-Cited by-同舟云学术

p62 is a useful predictive marker for tumour regression after chemoradiation therapy in patients with advanced rectal cancer: an immunohistochemical study

Published:2021-01-09 Issue:5 Volume:23 Page:1083-1090
ISSN:1462-8910
Container-title:Colorectal Disease
language:en
Short-container-title:Colorectal Dis

Author:

Kobayashi Toshinori¹^ORCID,Ishida Mitsuaki²,Miki Hisanori¹,Matsumi Yuki¹,Fukui Toshiro³,Hamada Madoka¹,Tsuta Koji²,Sekimoto Mitsugu¹

Affiliation:

1. Department of Surgery Kansai Medical University Osaka Japan

2. Department of Pathology and Clinical Laboratory Kansai Medical University Osaka Japan

3. Division of Gastroenterology and Hepatology Third Department of Internal Medicine Kansai Medical University Osaka Japan

Publisher

Wiley

Subject

Gastroenterology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/codi.15486

Reference25 articles.

1. Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy

2. Quality of Life in Rectal Cancer Patients After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection – A Matched-Controlled Study

3. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study

4. Predictive value of endoscopic features for a complete response after chemoradiotherapy for rectal cancer;Sande ME;Ann Surg,2019

5. Biomarker-Based Scoring System for Prediction of Tumor Response After Preoperative Chemoradiotherapy in Rectal Cancer by Reverse Transcriptase Polymerase Chain Reaction Analysis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical application of autophagy proteins as prognostic biomarkers in colorectal cancer: a meta-analysis;Future Oncology;2022-10

2. High Expression of p62 and ALDH1A3 Is Associated With Poor Prognosis in Luminal B Breast Cancer;Anticancer Research;2022-07